Predicting the individual clinical course remains a major issue in biomarker research in Alzheimer’s disease to adapt the therapeutic care of patients. Imaging data may contain valuable early markers of the clinical evolution of AD. In this study, we investigated the prognostic value of some imaging markers for the prediction of the clinical evolution of mild cognitive impairment (MCI) and AD patients over 24 months through both the conversion and the cognitive decline problems. With a rigorous validation scheme, for each clinical outcome, we built competitive predictive models on the ADNI cohort which are highly generalizable to other independent cohorts (OASIS and AddNeuroMed).
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords